Current cancer chips mainly use commercialized matrices, such as collagen I, laminin, and fibronectin, to model the TME, although these materials contain only a single structural protein that poorly reflects the heterogeneity of the tumor ECM [171]. The gene discussed is FN1; the disease is neoplasm.